Key result
TEER is linked to increased peak exercise cardiac output despite unchanged peak VO2.
Why the study?
Changes in peak exercise oxygen uptake and cardiac output 6 months after successful percutaneous edge-to-edge mitral valve repair in severe primary and functional mitral regurgitation patients were unknown.
Does percutaneous edge-to-edge mitral valve repair improve rest and exercise oxygen uptake and cardiac output in patients with severe primary and functional mitral regurgitation?
Observational (n=145)
Does percutaneous edge-to-edge mitral valve repair improve rest and exercise oxygen uptake and cardiac output in patients with severe primary and functional mitral regurgitation?
Successful percutaneous edge-to-edge mitral valve repair induces reverse ventricular remodeling and increases cardiac output during exercise, though peak oxygen uptake remains unchanged due to altered oxygen extraction.
Answers are grounded in this paper and cite their sources.
May enhance exercise hemodynamics without VO2 gain; leaves open randomized confirmation of clinical benefit in severe MR.
Aims Changes in peak exercise oxygen uptake (VO2) and cardiac output (CO) 6 months after successful percutaneous edge-to-edge mitral valve repair (pMVR) in severe primary (PMR) and functional mitral regurgitation (FMR) patients are unknown. The aim of the study was to assess the efficacy of pMVR at rest by echocardiography, VO2 and CO (inert gas rebreathing) measurement and during cardiopulmonary exercise test with CO measurement. Methods and results We evaluated 145 and 115 patients at rest and 98 and 66 during exercise before and after pMVR, respectively. After successful pMVR, significant reductions in MR and NYHA class were observed in FMR and PMR patients. Cardiac ultrasound showed reverse remodelling (left ventricular end-diastolic volume from 158 ± 63 mL to 147 ± 64, P < 0.001; ejection fraction from 51 ± 15 to 48 ± 14, P < 0.001; pulmonary artery systolic pressure (PASP) from 43 ± 13 to 38 ± 8 mmHg, P < 0.001) in the entire population. These changes were significant in PMR (n = 62) and a trend in FMR (n = 53), except for PASP, which decreased in both groups. At rest, CO and stroke volume (SV) increased in FMR with a concomitant reduction in arteriovenous O2 content difference [ΔC(a-v)O2]. Peak exercise, CO and SV increased significantly in both groups (CO from 5.5 ± 1.4 L/min to 6.3 ± 1.5 and from 6.2 ± 2.4 to 6.7 ± 2.0, SV from 57 ± 19 mL to 66 ± 20 and from 62 ± 20 to 69 ± 20, in FMR and PMR, respectively), whereas peak VO2 was unchanged and ΔC(a-v)O2 decreased. Conclusions These data confirm pMVR-induced clinical improvement and reverse ventricular remodelling at a 6-month analysis and show, in spite of an increase in CO, an unchanged exercise performance, which is achieved through a ‘more physiological’ blood flow distribution and O2 extraction behaviour. Direct rest and exercise CO should be measured to assess pMVR efficacy.
No takes yet. Share an insight, caveat, or question.
Vignati et al. (2021) conducted an observational in Severe primary and functional mitral regurgitation (n=145). Percutaneous edge-to-edge mitral valve repair (pMVR) vs. Baseline (pre-procedure) was evaluated on Changes in peak exercise oxygen uptake (VO2) and cardiac output (CO) at 6 months. Percutaneous edge-to-edge mitral valve repair increased peak exercise cardiac output (from 5.5 to 6.3 L/min in FMR and 6.2 to 6.7 L/min in PMR) at 6 months, while peak VO2 was unchanged.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: